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Abstract
Background: Diabetes mellitus is a common metabolic disorder which is increasing worldwide. This study aimed
to undertake a survey of the diabetes research in Iran to identify gaps and highlight strengths in order to develop a
roadmap for diabetes research in Iran for the next years.
Methods: To develop a roadmap and to identify major areas of diabetes research, we carried out a systematic
assessment of Iranian diabetes research publications. All obtained studies were categorized to 11 groups and each
group was classified according to the “study design”, “subject area”, “World Health Organization (WHO)
classification”, and “Australian Standard Research Classifications”. The number of publications per each year was
calculated. Research trends in publications in each area were assessed and compared.
Conclusion: By this study, we will provide the highlighted priorities, the gaps of research and strategic mapping of
each area of diabetes research that could serve as a precious guideline for national research initiatives in the field of
diabetes. By a strategic map, we can achieve many advances in the all aspects of diabetes research that finally
impact on the health, quality of life and well-being of diabetic patients.
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Background
Diabetes mellitus is one of the most important chronic
diseases and the major health challenge worldwide. The
prevalence of diabetes has reached epidemic proportions
in most populations and it is expected to continue to
rise [1]. The International Diabetes Foundation (IDF) es-
timates that 32 million adults in the Middle East and
North Africa (MENA) currently have diabetes, account-
ing for 9.3% of the world’s adults with the disease and
this number will double to 59.9 million by 2030 [2]. In a
nationally representative’s report of diabetes in Iran, it is
found that 11.37% of adults (2 million persons) have dia-
betes among whom 25% are not diagnosed [3]. Diabetes
imposes a large economic burden on individuals and
families, national health systems, and countries. The glo-
bal health expenditures for prevention and care of dia-
betes, its complications, disability and premature
mortality were USD 376 billion in 2010. By 2030, this
number will exceed some USD 490 billion. The
MENA region spends USD 5.5 billion annually on
diabetes, accounting for 14% of its total health care
expenditure [4]. In Iran, also, diabetes is a costly dis-
ease and consumes more than 8.6% of total health ex-
penditure (USD 3.78 bilion) [5]. Diabetic patients
have four times higher levels of hospitalization, 2.6
times higher numbers of annual physician visits and
2.5 times greater volume of drug prescriptions than
non- diabetic patients [6].
These findings, along with the epidemiological and fi-
nancial data, point to an imperative need to broaden re-
search strategies for prevention and management of
diabetes and its complications. Diabetes research have
led to significant advances in understanding the causes
and molecular pathways of diabetes and its complica-
tions, as well as new approaches and technologies for
prevention and management. Remarkable progress has
also been made on the development of sustainable
health care delivery system. Despite significant advances
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in prevention and management of diabetes and its com-
plications, there is currently no known cures or preven-
tion for diabetes.
Therefore, a critical goal for research is to find ways
that create lasting health benefits for people with or at
risk for diabetes and alleviate the societal burden of this
devastating disease. In this field, previous diabetes road
maps charted in the United States and the Europe. In
the United States, Australia, Canada and UK, diabetes
road maps planed where the juvenile Diabetes Research
Foundation (JDRE) has funded international research in
type 1 diabetes and its complications since 1997 [7, 8].
In 2010, the Australian Type 1 Diabetes Research
Agenda presented a strategic research plan designed to
identify research strengths and define research priorities
in the field. Another project “Type 1 Diabetes Research
Roadmap” is also funded by JDRF to understand the
strengths, weaknesses and opportunities in UK research
[9]. A strategic mapping process for a large scale plan
embracing all scientific areas has been used by the
European Strategy Forum on Research Infrastructures
(ESFRI). This map was organized in order to prepare fu-
ture EU activities supporting the integration of and ac-
cess to existing national research infrastructures [10].
The DIAMAP is one of the most important diabetes
research maps in Europe. The DIAMAP provides stra-
tegic guidance for diabetes research activity in Europe
for the benefit of all people with this disease [11].
Middle East is much more complicated geographically
and politically than the Europe and USA. It is made up
of individual nations, each with their own vastly differing
research budgets, and many differences in research facil-
ities. Health research challenges are also not necessarily
the same for each country. Cosidering our country eco-
nomic, social and cultural status and its differences with
others, we need to have a strategic research map plan
for own region to apply research findings in developing
national guidelines [12].
Therefore, the Iranian Diabetes Research Network
(IDRN) and its member universities of medical sciences
across the country, decided to design a map for diabetes
research. In June 2012, the Ministry of Health agreed to
collaborate with IDRN to achieve a strategic plan for the
sustainable development of diabetes research in Iran,
with better coordination of research and more rational
(science-based) use of funds, for the benefit of individ-
uals with diabetes.
Missions, goals and major objectives
The road map is intended to guide future investment in
diabetes research by policy makers or researchers inter-
ested in this strategic plan. The map covers research
areas considered by a group of leading experts to offer
the greatest scientific interest and potential for
advancing the field, ultimately for benefit to the patient.
This new Iranian strategy for diabetes research is ra-
tional, science-driven and takes into consideration the
unique expertise and opportunities in Iran.
The mission of roadmap is to chart the future of dia-
betes research in Iran for the benefit of all people with
the disease. To this end, IDRN will undertake a survey
of the diabetes research in Iran to identify gaps and
highlight strengths in order to develop a strategic plan
for diabetes research in Iran for the next years.
The specific objectives for the Iranian Diabetes
Research Roadmap (IDRR) are:
 To create diabetes research databases from a survey
of research activities in Iran.
 To compare this database with diabetes research
activities in the world.
 To produce a strategic diabetes roadmap to guide
future strategy for diabetes research in Iran.
Methods
Academic members and their activities
Iranian Diabetes Research Roadmap has been coordi-
nated by IDRN and overseen by a Project Steering
Committee (PSC) of high-profile members of aca-
demic science which provides scientific guidance to
the project (Fig. 1).
To achieve the main objectives of this project, we had
an overview on diabetes research trends in the world
and compared them with their counterparts in Iran. We
have described the methods of this study in detail in our
preliminary study [13].
The first step to draw a diabetes roadmap, was to
undertake a wide survey on Iranian diabetes research
and compare it with the world to identify gaps and high-
light strength. Therefore, diabetes research has been
considered in its broadest sense embracing, where possible,
all aspects of this complex field, from molecules, cells and
tissues, to whole animal studies, and clinical science and
care. The steering committee suggested a list of 11 scientific
areas of important opportunity related to diabetes. These
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Based on the number of scientific areas, the diverse
and talented group of researchers were voluntarily put
into 11 groups. Each working group was chaired by an
expert with comprehensive scientific knowledge in the
relevant focus area and more broadly in diabetes re-
search. Groups begin working when training workshops
were held to explain the process and ensure that all
members of each group receive the same information.
Moreover, all researchers participated in the coordin-
ation workshop to share their experience. In these work-
shops they identified overarching goals to provide a
broad vision considered important for advancement in
the field. They additionally sent the project promotion
report to the steering group monthly.
Search strategy
This study included all studies published from the begin-
ning until the first of 2015 in national and international
journals by Iranian authors conducted in the field of dia-
betes. International databases including PubMed, Web of
Science and SCOPUS as well as national databases includ-
ing Scientific Information Database (SID), Indexing Arti-
cles Published in Iran Biomedical Journals (IranMedex)
and Iranian Magazines Database (Magiran) were used as
the source of information. The keywords used for English
database search were “Diabetes mellitus” and “Iran*” as
the author affiliations. These key terms were used accord-
ing to each database instructions and were combined
using “AND” and “OR” operators appropriately. For
search in national databases equivalent Farsi keywords
were used. This comprehensive search strategy without
any limitation obtained 8668 publications in international
journals and 16,921 documents in national journals (a
total of 25,589). After assignment, duplications were re-
moved by reviewing the document title as well as the jour-
nal volume and issue. As there was a considerable overlap
between these databases, the number of obtained docu-
ments decreased significantly after removing duplicates.
These studies underwent screening based on the abstract
and content if required. In this stage, unrelated topics, let-
ter to the editors, meeting abstracts, news, as well as stud-
ies on foreign population were excluded and finally 5537
documents remained. In the next step, all obtained articles
from databases were merged and categorized according to
the articles’ titles to 11 groups as described above. Each
category was assigned to a study team member. Two
independent researchers performed each step. A third in-
vestigator adjudicated discrepancies between the two
reviewers.
Categorization of articles
Then, each working group categorized, assigned docu-
ments based on the “Australian Standard Research
Classifications”, the “World Health Organization (WHO)
classification”, “study design”, and “subject area”.
Australian standard research classifications
The Australian research classification system has been in
use for several decades and is updated approximately
every 10 years to take account of the new and changing
field. The National Health and Medical Research Coun-
cil (NHMRC)’s broad Research Area classification (Basic
Science, Clinical Medicine and Science, Health Services
Research, Public Health) have been developed by the
Australian Bureau of Statistics (ABS) and published as
the Australian and New Zealand Standard Research
Classification (ANZSRC) [14].
WHO classification
Four categories of research are specified in the current
typology of health research applicable to WHO [15].
These are:
i) Situation analyses which aims to identify the
distribution and determinants of health and disease,
and risk factors as well as policy analysis
Fig. 1 Flowchart of the “Iranian Diabetes Research Roadmap” members and their activities
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ii) Health policy and systems research that seeks to
improve the delivery, efficiency, effectiveness, equity
of health systems, guide health policy development
and optimize implementation of health programs;
iii)Product development and intervention research
which aims to develop new and improved tools for
health promotion and disease control, and to
promote implementation research; and
iv) Basic research that aims to advance knowledge of
basic biology with particular reference to potential
application in tackling human disorders, and to
expand human behavior, poverty, dynamics of social
organization [14].
Study design classification
The study design is the formulation of studies in med-
ical, clinical and other types of research (e.g., epidemio-
logical). There are many ways to classify research
designs, but sometimes the distinction is artificial and
other times different designs are combined.
Scientific studies can be classified as “Observational
Studies”, “Basic Studies”, Experimental (Interventional)
Studies”, and “Meta-Analysis – Systematic review” [9].
The list in Table 1 offers a number of useful distinc-
tions between possible research designs:
Observational studies can be defined as non-
interventional and non-experimental [16]. They can be
classified as descriptive (Case report, Case series and Cross-
sectional) or analytical (Cross-sectional, Case–control, and
cohort).
Basic studies focus on in-vitro or in-vivo studies such
as animal experiment, genetic and cell studies and also,
method development studies. Because the designs of
these studies are very different, we’ve put this group of
studies in a separate category.
Experimental or interventional studies compare the ef-
fect of treatments or interventions with control group.
When the preference of participants is not to receive a
placebo or control, randomization procedure is not
applied. These studies are called Non-Randomized
Controlled Studies.
Reviews evaluate evidence of studies conducted in a
clinical area. Systematic Review interprets all studies
in a determined area. Meta-Analysis uses statistical
techniques to synthesize the data from several studies
into a single quantitative estimate and provide a clear
conclusion.
Qualitative studies are for understanding of underlying
reasons, opinions, and motivations. Data collection
methods vary by unstructured or semi-structured tech-
niques. Some common methods include focus groups
(group discussions), individual interviews, and participa-
tion/observations.
Subject area classification
According to the research field, each working group cat-
egorized documents on top subject areas.
Trend of publications in the field of diabetes
The number of publications per year was calculated and
the proportion of publications within each research area
normalized by the total number of publications within
the specific research area. This allows the relative growth
in each research area to be observed. Research trends in
publications in each area were assessed and compared.
Future activities
The purpose of this project was to establish the priority
objectives for diabetes research in Iran, and then to in-
vestigate the most realistic and effective ways in which
these objectives can be integrated to deliver tangible
benefits for people with diabetes. Therefore, to identify
potential research gaps and research priorities for each
research area, multi- disciplinary expert groups will be
invited. The activities of these groups are as follows:
 To determine the similarities and differences
between the diabetes research in the world and Iran.
 To recognize the strengths and limitations of
diabetes research in Iran.
 Identifying research roadblocks that impede
progress across specific areas of diabetes research.
 Assessing ways in which these roadblocks could be
overcome.
 Establishing research priorities in each research area
for future studies.
Multi- disciplinary expert groups will determine ap-
propriate and realistic goals for patient- centered
Table 1 Study design classification
Methodology
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research in each area of diabetes. They will devise
and assess the similarities and differences between
the diabetes research in the world and Iran and list
the most important scientific advances in individual
fields that have an impact on current research. Goals
and specific milestones will be considered as a prior-
ity and roadblocks that may restrict progress along a
given research track will be highlighted and practical
strategies to overcome them put in place and new
research can be introduced to optimize delivery of
the goals. Further, research gaps will be recognized
in the research process that can aid planning of fur-
ther research by reducing duplication of research ef-
fort within areas, and focusing research efforts on
high priority topics.
After identification of high priority research topics,
they will be ranked for future studies of diabetes by
multi- disciplinary expert groups. These ranked priorities
may be overlap and repetition across and between
groups. These groups will also identify comprehensive
and useful maps, which will take the appearance of find-
ing gaps and research priorities. These roadmaps are
intended to guide future investment in diabetes research
in Iran. The roadmaps cover research areas considered
by a group of leading experts to offer the greatest scien-
tific interest and potential for advancing the field, ultim-
ately of benefit to the patient.
Research maps developed by each group will be com-
piled into a single “Iranian Diabetes Research Roadmap”
to provide the IDRN to maximize the strengths and op-
portunities for future diabetes research in Iran. The
“Iranian Diabetes Research Roadmap” has produced evi-
dence documents that may be useful to research.
Conclusion
This project could provide a highly original platform for
developing a strategy for diabetes research that is ra-
tional and science-based in Iran. The primary goal of the
project is to guide choice research areas for future dia-
betes research. Therefore, for this plan to be successful,
it will require monitoring, updating and refining by sci-
entific experts in the diabetes research field so that new
and emerging opportunities can be identified. The Iran
diabetes roadmap will be updated each 5 years to iden-
tify new research gaps.
We will soon provide the highlighted priorities, the
gaps of research and strategic mapping of each area of
diabetes research that could serve as a precious guide-
line for national research initiatives in the field of dia-
betes. By review and assess of strategic mapping, we can
achieve many advances in the all aspects of diabetes re-
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